Moneta Group Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Moneta Group Investment Advisors's EW Position: Q1 2026 in Review
Moneta Group Investment Advisors reduced its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, selling an estimated $17.9K and leaving 11,173 shares worth $895K. The position accounts for 0.01% of the portfolio, ranked #377.
Moneta Group Investment Advisors first reported a position in EW in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.81M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Moneta Group Investment Advisors held 11,173 shares of Edwards Lifesciences worth $895K as of Q1 2026.
- Moneta Group Investment Advisors sold 217 Edwards Lifesciences shares in Q1 2026, an estimated $17.9K.
- Edwards Lifesciences made up 0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #377 holding.
- Moneta Group Investment Advisors first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 23 quarters since.
- Moneta Group Investment Advisors's Edwards Lifesciences position peaked at $1.81M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.